nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—brain cancer—Betamethasone—hematologic cancer	0.0753	0.5	CpDpCtD
Triamcinolone—brain cancer—Dexamethasone—hematologic cancer	0.0753	0.5	CpDpCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0706	0.262	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0706	0.262	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.066	0.245	CiPCiCtD
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0623	0.231	CiPCiCtD
Triamcinolone—NR3C1—hematologic cancer	0.0566	1	CbGaD
Triamcinolone—Betamethasone—hematologic cancer	0.0498	0.261	CrCtD
Triamcinolone—Dexamethasone—hematologic cancer	0.0498	0.261	CrCtD
Triamcinolone—Prednisone—hematologic cancer	0.0462	0.242	CrCtD
Triamcinolone—Prednisolone—hematologic cancer	0.0451	0.236	CrCtD
Triamcinolone—PTGS2—Lenalidomide—hematologic cancer	0.0141	0.125	CbGbCtD
Triamcinolone—SERPINA6—Prednisolone—hematologic cancer	0.0134	0.119	CbGbCtD
Triamcinolone—PTGS2—Thalidomide—hematologic cancer	0.00751	0.0668	CbGbCtD
Triamcinolone—NR3C1—Betamethasone—hematologic cancer	0.00633	0.0563	CbGbCtD
Triamcinolone—NR3C1—Prednisolone—hematologic cancer	0.00625	0.0556	CbGbCtD
Triamcinolone—NR3C1—Prednisone—hematologic cancer	0.0059	0.0525	CbGbCtD
Triamcinolone—BCHE—Irinotecan—hematologic cancer	0.00513	0.0456	CbGbCtD
Triamcinolone—PTGS2—Betamethasone—hematologic cancer	0.00447	0.0398	CbGbCtD
Triamcinolone—BCHE—Cisplatin—hematologic cancer	0.00418	0.0372	CbGbCtD
Triamcinolone—NR3C1—Dexamethasone—hematologic cancer	0.00368	0.0328	CbGbCtD
Triamcinolone—PTGS2—Cisplatin—hematologic cancer	0.00322	0.0286	CbGbCtD
Triamcinolone—PTGS2—Etoposide—hematologic cancer	0.00316	0.0281	CbGbCtD
Triamcinolone—CYP3A4—Bexarotene—hematologic cancer	0.00278	0.0247	CbGbCtD
Triamcinolone—PTGS2—Dexamethasone—hematologic cancer	0.0026	0.0231	CbGbCtD
Triamcinolone—CYP3A4—Busulfan—hematologic cancer	0.00259	0.023	CbGbCtD
Triamcinolone—CYP3A4—Lomustine—hematologic cancer	0.00259	0.023	CbGbCtD
Triamcinolone—CYP3A4—Thiotepa—hematologic cancer	0.0023	0.0205	CbGbCtD
Triamcinolone—CYP3A4—Methoxsalen—hematologic cancer	0.00179	0.0159	CbGbCtD
Triamcinolone—Fluticasone furoate—Betamethasone—hematologic cancer	0.00172	0.0121	CrCrCtD
Triamcinolone—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00172	0.0121	CrCrCtD
Triamcinolone—CYP3A4—Bortezomib—hematologic cancer	0.0017	0.0152	CbGbCtD
Triamcinolone—CYP3A4—Daunorubicin—hematologic cancer	0.00163	0.0145	CbGbCtD
Triamcinolone—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00155	0.0109	CrCrCtD
Triamcinolone—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00155	0.0109	CrCrCtD
Triamcinolone—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—Halobetasol Propionate—Betamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—Fluticasone Propionate—Betamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—Difluprednate—Dexamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—Difluprednate—Betamethasone—hematologic cancer	0.0015	0.0105	CrCrCtD
Triamcinolone—CYP3A4—Cytarabine—hematologic cancer	0.00144	0.0128	CbGbCtD
Triamcinolone—CYP3A4—Teniposide—hematologic cancer	0.00142	0.0126	CbGbCtD
Triamcinolone—Fluocinonide—Betamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Fluocinonide—Dexamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Beclomethasone—Dexamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Prednicarbate—Betamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Prednicarbate—Dexamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Testolactone—Dexamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Testolactone—Betamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Beclomethasone—Betamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Clocortolone—Betamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—Clocortolone—Dexamethasone—hematologic cancer	0.00141	0.00989	CrCrCtD
Triamcinolone—PTGS2—ovarian follicle—hematologic cancer	0.00138	0.268	CbGeAlD
Triamcinolone—Fluocortolone—Dexamethasone—hematologic cancer	0.00137	0.0096	CrCrCtD
Triamcinolone—Fluocortolone—Betamethasone—hematologic cancer	0.00137	0.0096	CrCrCtD
Triamcinolone—Alclometasone—Dexamethasone—hematologic cancer	0.00133	0.00934	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00133	0.00934	CrCrCtD
Triamcinolone—Alclometasone—Betamethasone—hematologic cancer	0.00133	0.00934	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00133	0.00934	CrCrCtD
Triamcinolone—CYP3A4—Ifosfamide—hematologic cancer	0.00131	0.0116	CbGbCtD
Triamcinolone—Prednicarbate—Prednisone—hematologic cancer	0.00131	0.00917	CrCrCtD
Triamcinolone—Testolactone—Prednisone—hematologic cancer	0.00131	0.00917	CrCrCtD
Triamcinolone—Amcinonide—Betamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Fluoxymesterone—Betamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Budesonide—Betamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Amcinonide—Dexamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Budesonide—Dexamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Fluoxymesterone—Dexamethasone—hematologic cancer	0.00129	0.00909	CrCrCtD
Triamcinolone—Clocortolone—Prednisolone—hematologic cancer	0.00128	0.00895	CrCrCtD
Triamcinolone—Testolactone—Prednisolone—hematologic cancer	0.00128	0.00895	CrCrCtD
Triamcinolone—Prednicarbate—Prednisolone—hematologic cancer	0.00128	0.00895	CrCrCtD
Triamcinolone—Beclomethasone—Prednisolone—hematologic cancer	0.00128	0.00895	CrCrCtD
Triamcinolone—Fluocortolone—Prednisone—hematologic cancer	0.00127	0.0089	CrCrCtD
Triamcinolone—Diflorasone—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Fludrocortisone—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Flunisolide—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Fludrocortisone—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Flunisolide—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Diflorasone—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Prednisone—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Prednisone—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Desonide—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Desonide—Dexamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—Clobetasol propionate—Betamethasone—hematologic cancer	0.00126	0.00885	CrCrCtD
Triamcinolone—CYP3A4—Imatinib—hematologic cancer	0.00125	0.0111	CbGbCtD
Triamcinolone—Fluocortolone—Prednisolone—hematologic cancer	0.00124	0.00869	CrCrCtD
Triamcinolone—Alclometasone—Prednisone—hematologic cancer	0.00123	0.00866	CrCrCtD
Triamcinolone—Paramethasone—Dexamethasone—hematologic cancer	0.00123	0.00863	CrCrCtD
Triamcinolone—Paramethasone—Betamethasone—hematologic cancer	0.00123	0.00863	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.0012	0.00845	CrCrCtD
Triamcinolone—Alclometasone—Prednisolone—hematologic cancer	0.0012	0.00845	CrCrCtD
Triamcinolone—Amcinonide—Prednisone—hematologic cancer	0.0012	0.00843	CrCrCtD
Triamcinolone—Budesonide—Prednisone—hematologic cancer	0.0012	0.00843	CrCrCtD
Triamcinolone—Desoximetasone—Betamethasone—hematologic cancer	0.0012	0.00842	CrCrCtD
Triamcinolone—Desoximetasone—Dexamethasone—hematologic cancer	0.0012	0.00842	CrCrCtD
Triamcinolone—CYP3A4—Ruxolitinib—hematologic cancer	0.00118	0.0105	CbGbCtD
Triamcinolone—Fluoxymesterone—Prednisolone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Budesonide—Prednisolone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Amcinonide—Prednisolone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Fluorometholone—Betamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Fluorometholone—Dexamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Mometasone—Dexamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Mometasone—Betamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Loteprednol—Betamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Loteprednol—Dexamethasone—hematologic cancer	0.00117	0.00822	CrCrCtD
Triamcinolone—Diflorasone—Prednisone—hematologic cancer	0.00117	0.00821	CrCrCtD
Triamcinolone—Flunisolide—Prednisone—hematologic cancer	0.00117	0.00821	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisone—hematologic cancer	0.00117	0.00821	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisone—hematologic cancer	0.00117	0.00821	CrCrCtD
Triamcinolone—Desonide—Prednisone—hematologic cancer	0.00117	0.00821	CrCrCtD
Triamcinolone—Dexamethasone—Betamethasone—hematologic cancer	0.00114	0.00803	CrCrCtD
Triamcinolone—Rimexolone—Dexamethasone—hematologic cancer	0.00114	0.00803	CrCrCtD
Triamcinolone—Rimexolone—Betamethasone—hematologic cancer	0.00114	0.00803	CrCrCtD
Triamcinolone—Betamethasone—Dexamethasone—hematologic cancer	0.00114	0.00803	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Desonide—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Prednisone—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Diflorasone—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Flunisolide—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisolone—hematologic cancer	0.00114	0.00801	CrCrCtD
Triamcinolone—Paramethasone—Prednisone—hematologic cancer	0.00114	0.008	CrCrCtD
Triamcinolone—CYP3A4—Nilotinib—hematologic cancer	0.00114	0.0101	CbGbCtD
Triamcinolone—CYP3A4—Vinorelbine—hematologic cancer	0.00113	0.01	CbGbCtD
Triamcinolone—Paramethasone—Prednisolone—hematologic cancer	0.00111	0.00781	CrCrCtD
Triamcinolone—Desoximetasone—Prednisone—hematologic cancer	0.00111	0.00781	CrCrCtD
Triamcinolone—Methylprednisolone—Betamethasone—hematologic cancer	0.00109	0.00768	CrCrCtD
Triamcinolone—Methylprednisolone—Dexamethasone—hematologic cancer	0.00109	0.00768	CrCrCtD
Triamcinolone—Loteprednol—Prednisone—hematologic cancer	0.00109	0.00762	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00109	0.00762	CrCrCtD
Triamcinolone—Mometasone—Prednisone—hematologic cancer	0.00109	0.00762	CrCrCtD
Triamcinolone—Fluorometholone—Prednisone—hematologic cancer	0.00109	0.00762	CrCrCtD
Triamcinolone—Desoximetasone—Prednisolone—hematologic cancer	0.00109	0.00762	CrCrCtD
Triamcinolone—Prednisolone—Dexamethasone—hematologic cancer	0.00107	0.00752	CrCrCtD
Triamcinolone—Prednisolone—Betamethasone—hematologic cancer	0.00107	0.00752	CrCrCtD
Triamcinolone—Dexamethasone—Prednisone—hematologic cancer	0.00106	0.00745	CrCrCtD
Triamcinolone—Rimexolone—Prednisone—hematologic cancer	0.00106	0.00745	CrCrCtD
Triamcinolone—Betamethasone—Prednisone—hematologic cancer	0.00106	0.00745	CrCrCtD
Triamcinolone—Loteprednol—Prednisolone—hematologic cancer	0.00106	0.00744	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00106	0.00744	CrCrCtD
Triamcinolone—Fluorometholone—Prednisolone—hematologic cancer	0.00106	0.00744	CrCrCtD
Triamcinolone—Mometasone—Prednisolone—hematologic cancer	0.00106	0.00744	CrCrCtD
Triamcinolone—Dexamethasone—Prednisolone—hematologic cancer	0.00104	0.00727	CrCrCtD
Triamcinolone—Betamethasone—Prednisolone—hematologic cancer	0.00104	0.00727	CrCrCtD
Triamcinolone—Rimexolone—Prednisolone—hematologic cancer	0.00104	0.00727	CrCrCtD
Triamcinolone—Hydrocortisone—Betamethasone—hematologic cancer	0.00103	0.00722	CrCrCtD
Triamcinolone—Hydrocortisone—Dexamethasone—hematologic cancer	0.00103	0.00722	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisone—hematologic cancer	0.00102	0.00712	CrCrCtD
Triamcinolone—CYP3A4—Dasatinib—hematologic cancer	0.001	0.00892	CbGbCtD
Triamcinolone—Prednisolone—Prednisone—hematologic cancer	0.000994	0.00697	CrCrCtD
Triamcinolone—CYP3A4—Mitoxantrone—hematologic cancer	0.000991	0.00881	CbGbCtD
Triamcinolone—Methylprednisolone—Prednisolone—hematologic cancer	0.000991	0.00695	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisone—hematologic cancer	0.000954	0.00669	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisolone—hematologic cancer	0.000931	0.00653	CrCrCtD
Triamcinolone—CYP3A4—Betamethasone—hematologic cancer	0.000883	0.00786	CbGbCtD
Triamcinolone—CYP3A4—Prednisolone—hematologic cancer	0.000872	0.00775	CbGbCtD
Triamcinolone—CYP3A4—Prednisone—hematologic cancer	0.000823	0.00732	CbGbCtD
Triamcinolone—CYP3A4—Irinotecan—hematologic cancer	0.00078	0.00694	CbGbCtD
Triamcinolone—CYP3A4—Vinblastine—hematologic cancer	0.000694	0.00617	CbGbCtD
Triamcinolone—CYP3A4—Vincristine—hematologic cancer	0.000682	0.00607	CbGbCtD
Triamcinolone—CYP3A4—Etoposide—hematologic cancer	0.000625	0.00556	CbGbCtD
Triamcinolone—CYP3A4—Dexamethasone—hematologic cancer	0.000514	0.00457	CbGbCtD
Triamcinolone—SERPINA6—hematopoietic system—hematologic cancer	0.00044	0.0854	CbGeAlD
Triamcinolone—CYP3A4—Doxorubicin—hematologic cancer	0.000426	0.00379	CbGbCtD
Triamcinolone—SERPINA6—blood—hematologic cancer	0.000292	0.0566	CbGeAlD
Triamcinolone—SERPINA6—bone marrow—hematologic cancer	0.000282	0.0547	CbGeAlD
Triamcinolone—SERPINA6—lung—hematologic cancer	0.000256	0.0496	CbGeAlD
Triamcinolone—BCHE—hematopoietic system—hematologic cancer	0.000216	0.042	CbGeAlD
Triamcinolone—NR3C1—hematopoietic system—hematologic cancer	0.000193	0.0374	CbGeAlD
Triamcinolone—PTGS2—hematopoietic system—hematologic cancer	0.000167	0.0324	CbGeAlD
Triamcinolone—NR3C1—gonad—hematologic cancer	0.000147	0.0284	CbGeAlD
Triamcinolone—CYP3A4—hematopoietic system—hematologic cancer	0.000146	0.0283	CbGeAlD
Triamcinolone—BCHE—blood—hematologic cancer	0.000143	0.0278	CbGeAlD
Triamcinolone—BCHE—bone marrow—hematologic cancer	0.000139	0.0269	CbGeAlD
Triamcinolone—NR3C1—blood—hematologic cancer	0.000128	0.0248	CbGeAlD
Triamcinolone—BCHE—lung—hematologic cancer	0.000126	0.0244	CbGeAlD
Triamcinolone—NR3C1—bone marrow—hematologic cancer	0.000124	0.024	CbGeAlD
Triamcinolone—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	0.000119	0.312	CbGdCrCtD
Triamcinolone—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	0.000119	0.312	CbGdCrCtD
Triamcinolone—BCHE—testis—hematologic cancer	0.000119	0.023	CbGeAlD
Triamcinolone—NR3C1—lung—hematologic cancer	0.000112	0.0217	CbGeAlD
Triamcinolone—PTGS2—blood—hematologic cancer	0.000111	0.0214	CbGeAlD
Triamcinolone—PTGS2—bone marrow—hematologic cancer	0.000107	0.0207	CbGeAlD
Triamcinolone—NR3C1—testis—hematologic cancer	0.000106	0.0205	CbGeAlD
Triamcinolone—PTGS2—lung—hematologic cancer	9.69e-05	0.0188	CbGeAlD
Triamcinolone—CYP3A4—blood—hematologic cancer	9.66e-05	0.0187	CbGeAlD
Triamcinolone—BCHE—lymph node—hematologic cancer	8.6e-05	0.0167	CbGeAlD
Triamcinolone—NR3C1—lymph node—hematologic cancer	7.66e-05	0.0149	CbGeAlD
Triamcinolone—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	7.17e-05	0.188	CbGdCrCtD
Triamcinolone—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	7.17e-05	0.188	CbGdCrCtD
Triamcinolone—PTGS2—lymph node—hematologic cancer	6.63e-05	0.0129	CbGeAlD
Triamcinolone—Difluprednate—NR3C1—hematologic cancer	3.98e-05	0.0409	CrCbGaD
Triamcinolone—Clocortolone—NR3C1—hematologic cancer	3.86e-05	0.0397	CrCbGaD
Triamcinolone—Prednicarbate—NR3C1—hematologic cancer	3.86e-05	0.0397	CrCbGaD
Triamcinolone—Desonide—NR3C1—hematologic cancer	3.65e-05	0.0375	CrCbGaD
Triamcinolone—Diflorasone—NR3C1—hematologic cancer	3.65e-05	0.0375	CrCbGaD
Triamcinolone—Desoximetasone—NR3C1—hematologic cancer	3.56e-05	0.0366	CrCbGaD
Triamcinolone—Loteprednol—NR3C1—hematologic cancer	3.52e-05	0.0362	CrCbGaD
Triamcinolone—Fludrocortisone—AR—hematologic cancer	3.47e-05	0.0357	CrCbGaD
Triamcinolone—Flumethasone Pivalate—NR3C1—hematologic cancer	3.06e-05	0.0315	CrCbGaD
Triamcinolone—Halobetasol Propionate—NR3C1—hematologic cancer	3.02e-05	0.031	CrCbGaD
Triamcinolone—Fluoxymesterone—AR—hematologic cancer	2.86e-05	0.0294	CrCbGaD
Triamcinolone—Amcinonide—NR3C1—hematologic cancer	2.8e-05	0.0288	CrCbGaD
Triamcinolone—Budesonide—NR3C1—hematologic cancer	2.8e-05	0.0288	CrCbGaD
Triamcinolone—Fluticasone furoate—NR3C1—hematologic cancer	2.75e-05	0.0283	CrCbGaD
Triamcinolone—Mometasone—NR3C1—hematologic cancer	2.67e-05	0.0274	CrCbGaD
Triamcinolone—Rimexolone—NR3C1—hematologic cancer	2.64e-05	0.0271	CrCbGaD
Triamcinolone—Beclomethasone—NR3C1—hematologic cancer	2.49e-05	0.0256	CrCbGaD
Triamcinolone—Fluocinonide—NR3C1—hematologic cancer	2.49e-05	0.0256	CrCbGaD
Triamcinolone—Fluocinolone Acetonide—NR3C1—hematologic cancer	2.42e-05	0.0248	CrCbGaD
Triamcinolone—Alclometasone—NR3C1—hematologic cancer	2.42e-05	0.0248	CrCbGaD
Triamcinolone—Clobetasol propionate—NR3C1—hematologic cancer	2.35e-05	0.0242	CrCbGaD
Triamcinolone—Fludrocortisone—NR3C1—hematologic cancer	2.35e-05	0.0242	CrCbGaD
Triamcinolone—Flunisolide—NR3C1—hematologic cancer	2.35e-05	0.0242	CrCbGaD
Triamcinolone—Paramethasone—NR3C1—hematologic cancer	2.32e-05	0.0239	CrCbGaD
Triamcinolone—Fluorometholone—NR3C1—hematologic cancer	2.27e-05	0.0233	CrCbGaD
Triamcinolone—Fluoxymesterone—ESR1—hematologic cancer	2.21e-05	0.0227	CrCbGaD
Triamcinolone—Methylprednisolone—NR3C1—hematologic cancer	2.19e-05	0.0225	CrCbGaD
Triamcinolone—Fluoxymesterone—NR3C1—hematologic cancer	1.94e-05	0.02	CrCbGaD
Triamcinolone—Prednisone—NR3C1—hematologic cancer	1.68e-05	0.0172	CrCbGaD
Triamcinolone—Fluticasone Propionate—NR3C1—hematologic cancer	1.65e-05	0.017	CrCbGaD
Triamcinolone—Prednisolone—NR3C1—hematologic cancer	1.55e-05	0.0159	CrCbGaD
Triamcinolone—Betamethasone—NR3C1—hematologic cancer	1.51e-05	0.0156	CrCbGaD
Triamcinolone—Hydrocortisone—ABCG2—hematologic cancer	1.37e-05	0.0141	CrCbGaD
Triamcinolone—Fluticasone furoate—ABCB1—hematologic cancer	1.33e-05	0.0136	CrCbGaD
Triamcinolone—Hydrocortisone—NR3C1—hematologic cancer	1.18e-05	0.0121	CrCbGaD
Triamcinolone—Methylprednisolone—ABCB1—hematologic cancer	1.06e-05	0.0109	CrCbGaD
Triamcinolone—Dexamethasone—ABCG2—hematologic cancer	1.02e-05	0.0105	CrCbGaD
Triamcinolone—Dexamethasone—NR3C1—hematologic cancer	8.81e-06	0.00905	CrCbGaD
Triamcinolone—Prednisone—ALB—hematologic cancer	8.48e-06	0.00871	CrCbGaD
Triamcinolone—Prednisone—ABCB1—hematologic cancer	8.09e-06	0.00831	CrCbGaD
Triamcinolone—Prednisolone—ABCB1—hematologic cancer	7.46e-06	0.00766	CrCbGaD
Triamcinolone—Betamethasone—ABCB1—hematologic cancer	7.3e-06	0.00751	CrCbGaD
Triamcinolone—Hydrocortisone—ABCB1—hematologic cancer	5.7e-06	0.00586	CrCbGaD
Triamcinolone—Rash—Alitretinoin—hematologic cancer	5.04e-06	9.09e-05	CcSEcCtD
Triamcinolone—Dermatitis—Alitretinoin—hematologic cancer	5.04e-06	9.08e-05	CcSEcCtD
Triamcinolone—Vomiting—Ifosfamide—hematologic cancer	5.03e-06	9.06e-05	CcSEcCtD
Triamcinolone—Hypersensitivity—Cisplatin—hematologic cancer	5.02e-06	9.05e-05	CcSEcCtD
Triamcinolone—Tachycardia—Dexamethasone—hematologic cancer	5.02e-06	9.04e-05	CcSEcCtD
Triamcinolone—Tachycardia—Betamethasone—hematologic cancer	5.02e-06	9.04e-05	CcSEcCtD
Triamcinolone—Bradycardia—Epirubicin—hematologic cancer	5.02e-06	9.04e-05	CcSEcCtD
Triamcinolone—Headache—Alitretinoin—hematologic cancer	5.01e-06	9.03e-05	CcSEcCtD
Triamcinolone—Angioedema—Prednisone—hematologic cancer	5.01e-06	9.03e-05	CcSEcCtD
Triamcinolone—Nausea—Thalidomide—hematologic cancer	4.99e-06	9e-05	CcSEcCtD
Triamcinolone—Rash—Ifosfamide—hematologic cancer	4.98e-06	8.98e-05	CcSEcCtD
Triamcinolone—Dermatitis—Ifosfamide—hematologic cancer	4.98e-06	8.97e-05	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Doxorubicin—hematologic cancer	4.98e-06	8.97e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Dexamethasone—hematologic cancer	4.97e-06	8.95e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Betamethasone—hematologic cancer	4.97e-06	8.95e-05	CcSEcCtD
Triamcinolone—Dizziness—Irinotecan—hematologic cancer	4.96e-06	8.95e-05	CcSEcCtD
Triamcinolone—Urticaria—Etoposide—hematologic cancer	4.96e-06	8.94e-05	CcSEcCtD
Triamcinolone—Haemoglobin—Epirubicin—hematologic cancer	4.95e-06	8.92e-05	CcSEcCtD
Triamcinolone—Malaise—Prednisone—hematologic cancer	4.94e-06	8.91e-05	CcSEcCtD
Triamcinolone—Rhinitis—Epirubicin—hematologic cancer	4.94e-06	8.9e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Etoposide—hematologic cancer	4.94e-06	8.9e-05	CcSEcCtD
Triamcinolone—Conjunctivitis—Doxorubicin—hematologic cancer	4.94e-06	8.89e-05	CcSEcCtD
Triamcinolone—Vertigo—Prednisone—hematologic cancer	4.93e-06	8.88e-05	CcSEcCtD
Triamcinolone—Haemorrhage—Epirubicin—hematologic cancer	4.93e-06	8.88e-05	CcSEcCtD
Triamcinolone—Syncope—Prednisone—hematologic cancer	4.92e-06	8.86e-05	CcSEcCtD
Triamcinolone—Vomiting—Vincristine—hematologic cancer	4.9e-06	8.83e-05	CcSEcCtD
Triamcinolone—Urticaria—Prednisolone—hematologic cancer	4.89e-06	8.82e-05	CcSEcCtD
Triamcinolone—Asthenia—Cisplatin—hematologic cancer	4.89e-06	8.81e-05	CcSEcCtD
Triamcinolone—Pharyngitis—Epirubicin—hematologic cancer	4.89e-06	8.81e-05	CcSEcCtD
Triamcinolone—Rash—Vincristine—hematologic cancer	4.86e-06	8.76e-05	CcSEcCtD
Triamcinolone—Dermatitis—Vincristine—hematologic cancer	4.86e-06	8.75e-05	CcSEcCtD
Triamcinolone—Headache—Vincristine—hematologic cancer	4.83e-06	8.7e-05	CcSEcCtD
Triamcinolone—Loss of consciousness—Prednisone—hematologic cancer	4.82e-06	8.69e-05	CcSEcCtD
Triamcinolone—Nausea—Carmustine—hematologic cancer	4.8e-06	8.64e-05	CcSEcCtD
Triamcinolone—Epistaxis—Doxorubicin—hematologic cancer	4.79e-06	8.63e-05	CcSEcCtD
Triamcinolone—Vomiting—Irinotecan—hematologic cancer	4.77e-06	8.6e-05	CcSEcCtD
Triamcinolone—Vomiting—Mitoxantrone—hematologic cancer	4.77e-06	8.6e-05	CcSEcCtD
Triamcinolone—Nausea—Alitretinoin—hematologic cancer	4.75e-06	8.56e-05	CcSEcCtD
Triamcinolone—Convulsion—Prednisone—hematologic cancer	4.75e-06	8.56e-05	CcSEcCtD
Triamcinolone—Hypertension—Prednisone—hematologic cancer	4.73e-06	8.53e-05	CcSEcCtD
Triamcinolone—Rash—Irinotecan—hematologic cancer	4.73e-06	8.53e-05	CcSEcCtD
Triamcinolone—Rash—Mitoxantrone—hematologic cancer	4.73e-06	8.53e-05	CcSEcCtD
Triamcinolone—Dermatitis—Mitoxantrone—hematologic cancer	4.73e-06	8.52e-05	CcSEcCtD
Triamcinolone—Dermatitis—Irinotecan—hematologic cancer	4.73e-06	8.52e-05	CcSEcCtD
Triamcinolone—Headache—Irinotecan—hematologic cancer	4.7e-06	8.47e-05	CcSEcCtD
Triamcinolone—Headache—Mitoxantrone—hematologic cancer	4.7e-06	8.47e-05	CcSEcCtD
Triamcinolone—Nausea—Ifosfamide—hematologic cancer	4.7e-06	8.46e-05	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4.68e-06	8.44e-05	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4.68e-06	8.44e-05	CcSEcCtD
Triamcinolone—Myalgia—Prednisone—hematologic cancer	4.67e-06	8.41e-05	CcSEcCtD
Triamcinolone—Vomiting—Gemcitabine—hematologic cancer	4.65e-06	8.38e-05	CcSEcCtD
Triamcinolone—Insomnia—Dexamethasone—hematologic cancer	4.65e-06	8.38e-05	CcSEcCtD
Triamcinolone—Insomnia—Betamethasone—hematologic cancer	4.65e-06	8.38e-05	CcSEcCtD
Triamcinolone—Bradycardia—Doxorubicin—hematologic cancer	4.64e-06	8.36e-05	CcSEcCtD
Triamcinolone—Paraesthesia—Betamethasone—hematologic cancer	4.61e-06	8.32e-05	CcSEcCtD
Triamcinolone—Paraesthesia—Dexamethasone—hematologic cancer	4.61e-06	8.32e-05	CcSEcCtD
Triamcinolone—Discomfort—Prednisone—hematologic cancer	4.61e-06	8.31e-05	CcSEcCtD
Triamcinolone—Rash—Gemcitabine—hematologic cancer	4.61e-06	8.31e-05	CcSEcCtD
Triamcinolone—Dermatitis—Gemcitabine—hematologic cancer	4.61e-06	8.3e-05	CcSEcCtD
Triamcinolone—Hypersensitivity—Etoposide—hematologic cancer	4.6e-06	8.29e-05	CcSEcCtD
Triamcinolone—Erythema—Methotrexate—hematologic cancer	4.58e-06	8.26e-05	CcSEcCtD
Triamcinolone—Haemoglobin—Doxorubicin—hematologic cancer	4.58e-06	8.26e-05	CcSEcCtD
Triamcinolone—Headache—Gemcitabine—hematologic cancer	4.58e-06	8.26e-05	CcSEcCtD
Triamcinolone—Nausea—Vincristine—hematologic cancer	4.58e-06	8.25e-05	CcSEcCtD
Triamcinolone—Rhinitis—Doxorubicin—hematologic cancer	4.57e-06	8.24e-05	CcSEcCtD
Triamcinolone—Haemorrhage—Doxorubicin—hematologic cancer	4.56e-06	8.21e-05	CcSEcCtD
Triamcinolone—Hypersensitivity—Prednisolone—hematologic cancer	4.54e-06	8.18e-05	CcSEcCtD
Triamcinolone—Pharyngitis—Doxorubicin—hematologic cancer	4.52e-06	8.15e-05	CcSEcCtD
Triamcinolone—Dyspepsia—Betamethasone—hematologic cancer	4.52e-06	8.15e-05	CcSEcCtD
Triamcinolone—Dyspepsia—Dexamethasone—hematologic cancer	4.52e-06	8.15e-05	CcSEcCtD
Triamcinolone—Dysgeusia—Methotrexate—hematologic cancer	4.49e-06	8.09e-05	CcSEcCtD
Triamcinolone—Asthenia—Etoposide—hematologic cancer	4.48e-06	8.07e-05	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisone—hematologic cancer	4.48e-06	8.06e-05	CcSEcCtD
Triamcinolone—Oedema—Prednisone—hematologic cancer	4.48e-06	8.06e-05	CcSEcCtD
Triamcinolone—Nausea—Irinotecan—hematologic cancer	4.46e-06	8.04e-05	CcSEcCtD
Triamcinolone—Nausea—Mitoxantrone—hematologic cancer	4.46e-06	8.04e-05	CcSEcCtD
Triamcinolone—Infection—Prednisone—hematologic cancer	4.45e-06	8.01e-05	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—hematologic cancer	4.43e-06	7.99e-05	CcSEcCtD
Triamcinolone—Fatigue—Dexamethasone—hematologic cancer	4.43e-06	7.98e-05	CcSEcCtD
Triamcinolone—Fatigue—Betamethasone—hematologic cancer	4.43e-06	7.98e-05	CcSEcCtD
Triamcinolone—Pruritus—Etoposide—hematologic cancer	4.42e-06	7.96e-05	CcSEcCtD
Triamcinolone—Shock—Prednisone—hematologic cancer	4.4e-06	7.93e-05	CcSEcCtD
Triamcinolone—Arrhythmia—Epirubicin—hematologic cancer	4.4e-06	7.93e-05	CcSEcCtD
Triamcinolone—Pain—Dexamethasone—hematologic cancer	4.39e-06	7.92e-05	CcSEcCtD
Triamcinolone—Pain—Betamethasone—hematologic cancer	4.39e-06	7.92e-05	CcSEcCtD
Triamcinolone—Tachycardia—Prednisone—hematologic cancer	4.37e-06	7.87e-05	CcSEcCtD
Triamcinolone—Nausea—Gemcitabine—hematologic cancer	4.34e-06	7.83e-05	CcSEcCtD
Triamcinolone—Vomiting—Cisplatin—hematologic cancer	4.33e-06	7.81e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisone—hematologic cancer	4.33e-06	7.8e-05	CcSEcCtD
Triamcinolone—Rash—Cisplatin—hematologic cancer	4.3e-06	7.74e-05	CcSEcCtD
Triamcinolone—Dermatitis—Cisplatin—hematologic cancer	4.29e-06	7.74e-05	CcSEcCtD
Triamcinolone—Erythema—Epirubicin—hematologic cancer	4.29e-06	7.73e-05	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—hematologic cancer	4.25e-06	7.66e-05	CcSEcCtD
Triamcinolone—Dexamethasone—ABCB1—hematologic cancer	4.25e-06	0.00437	CrCbGaD
Triamcinolone—Feeling abnormal—Dexamethasone—hematologic cancer	4.23e-06	7.63e-05	CcSEcCtD
Triamcinolone—Feeling abnormal—Betamethasone—hematologic cancer	4.23e-06	7.63e-05	CcSEcCtD
Triamcinolone—Dysgeusia—Epirubicin—hematologic cancer	4.2e-06	7.57e-05	CcSEcCtD
Triamcinolone—Back pain—Epirubicin—hematologic cancer	4.15e-06	7.48e-05	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—hematologic cancer	4.13e-06	7.45e-05	CcSEcCtD
Triamcinolone—Dizziness—Etoposide—hematologic cancer	4.13e-06	7.44e-05	CcSEcCtD
Triamcinolone—Vertigo—Methotrexate—hematologic cancer	4.12e-06	7.42e-05	CcSEcCtD
Triamcinolone—Urticaria—Betamethasone—hematologic cancer	4.08e-06	7.36e-05	CcSEcCtD
Triamcinolone—Urticaria—Dexamethasone—hematologic cancer	4.08e-06	7.36e-05	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Prednisone—hematologic cancer	4.08e-06	7.35e-05	CcSEcCtD
Triamcinolone—Dizziness—Prednisolone—hematologic cancer	4.07e-06	7.34e-05	CcSEcCtD
Triamcinolone—Arrhythmia—Doxorubicin—hematologic cancer	4.07e-06	7.34e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Dexamethasone—hematologic cancer	4.06e-06	7.32e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Betamethasone—hematologic cancer	4.06e-06	7.32e-05	CcSEcCtD
Triamcinolone—Nausea—Cisplatin—hematologic cancer	4.05e-06	7.3e-05	CcSEcCtD
Triamcinolone—Insomnia—Prednisone—hematologic cancer	4.05e-06	7.29e-05	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisone—hematologic cancer	4.02e-06	7.24e-05	CcSEcCtD
Triamcinolone—Cough—Methotrexate—hematologic cancer	4e-06	7.21e-05	CcSEcCtD
Triamcinolone—Ill-defined disorder—Epirubicin—hematologic cancer	3.98e-06	7.17e-05	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—hematologic cancer	3.97e-06	7.16e-05	CcSEcCtD
Triamcinolone—Vomiting—Etoposide—hematologic cancer	3.97e-06	7.15e-05	CcSEcCtD
Triamcinolone—Erythema—Doxorubicin—hematologic cancer	3.97e-06	7.15e-05	CcSEcCtD
Triamcinolone—Dyspepsia—Prednisone—hematologic cancer	3.94e-06	7.1e-05	CcSEcCtD
Triamcinolone—Rash—Etoposide—hematologic cancer	3.94e-06	7.09e-05	CcSEcCtD
Triamcinolone—Dermatitis—Etoposide—hematologic cancer	3.93e-06	7.09e-05	CcSEcCtD
Triamcinolone—Headache—Etoposide—hematologic cancer	3.91e-06	7.05e-05	CcSEcCtD
Triamcinolone—Myalgia—Methotrexate—hematologic cancer	3.9e-06	7.03e-05	CcSEcCtD
Triamcinolone—Dysgeusia—Doxorubicin—hematologic cancer	3.89e-06	7e-05	CcSEcCtD
Triamcinolone—Rash—Prednisolone—hematologic cancer	3.88e-06	7e-05	CcSEcCtD
Triamcinolone—Dermatitis—Prednisolone—hematologic cancer	3.88e-06	6.99e-05	CcSEcCtD
Triamcinolone—Malaise—Epirubicin—hematologic cancer	3.87e-06	6.97e-05	CcSEcCtD
Triamcinolone—Fatigue—Prednisone—hematologic cancer	3.86e-06	6.95e-05	CcSEcCtD
Triamcinolone—Headache—Prednisolone—hematologic cancer	3.86e-06	6.95e-05	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—hematologic cancer	3.85e-06	6.95e-05	CcSEcCtD
Triamcinolone—Vertigo—Epirubicin—hematologic cancer	3.85e-06	6.94e-05	CcSEcCtD
Triamcinolone—Syncope—Epirubicin—hematologic cancer	3.85e-06	6.93e-05	CcSEcCtD
Triamcinolone—Back pain—Doxorubicin—hematologic cancer	3.84e-06	6.92e-05	CcSEcCtD
Triamcinolone—Loss of consciousness—Epirubicin—hematologic cancer	3.77e-06	6.79e-05	CcSEcCtD
Triamcinolone—Cough—Epirubicin—hematologic cancer	3.74e-06	6.74e-05	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methotrexate—hematologic cancer	3.74e-06	6.74e-05	CcSEcCtD
Triamcinolone—Convulsion—Epirubicin—hematologic cancer	3.72e-06	6.7e-05	CcSEcCtD
Triamcinolone—Infection—Methotrexate—hematologic cancer	3.72e-06	6.7e-05	CcSEcCtD
Triamcinolone—Nausea—Etoposide—hematologic cancer	3.71e-06	6.68e-05	CcSEcCtD
Triamcinolone—Hypertension—Epirubicin—hematologic cancer	3.7e-06	6.67e-05	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisone—hematologic cancer	3.69e-06	6.65e-05	CcSEcCtD
Triamcinolone—Asthenia—Dexamethasone—hematologic cancer	3.69e-06	6.64e-05	CcSEcCtD
Triamcinolone—Asthenia—Betamethasone—hematologic cancer	3.69e-06	6.64e-05	CcSEcCtD
Triamcinolone—Ill-defined disorder—Doxorubicin—hematologic cancer	3.68e-06	6.63e-05	CcSEcCtD
Triamcinolone—Nausea—Prednisolone—hematologic cancer	3.66e-06	6.59e-05	CcSEcCtD
Triamcinolone—Myalgia—Epirubicin—hematologic cancer	3.65e-06	6.58e-05	CcSEcCtD
Triamcinolone—Pruritus—Dexamethasone—hematologic cancer	3.64e-06	6.55e-05	CcSEcCtD
Triamcinolone—Pruritus—Betamethasone—hematologic cancer	3.64e-06	6.55e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—hematologic cancer	3.62e-06	6.52e-05	CcSEcCtD
Triamcinolone—Discomfort—Epirubicin—hematologic cancer	3.61e-06	6.5e-05	CcSEcCtD
Triamcinolone—Malaise—Doxorubicin—hematologic cancer	3.58e-06	6.45e-05	CcSEcCtD
Triamcinolone—Dry mouth—Epirubicin—hematologic cancer	3.57e-06	6.43e-05	CcSEcCtD
Triamcinolone—Vertigo—Doxorubicin—hematologic cancer	3.57e-06	6.42e-05	CcSEcCtD
Triamcinolone—Syncope—Doxorubicin—hematologic cancer	3.56e-06	6.41e-05	CcSEcCtD
Triamcinolone—Urticaria—Prednisone—hematologic cancer	3.56e-06	6.41e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Prednisone—hematologic cancer	3.54e-06	6.38e-05	CcSEcCtD
Triamcinolone—Anaphylactic shock—Epirubicin—hematologic cancer	3.5e-06	6.31e-05	CcSEcCtD
Triamcinolone—Oedema—Epirubicin—hematologic cancer	3.5e-06	6.31e-05	CcSEcCtD
Triamcinolone—Loss of consciousness—Doxorubicin—hematologic cancer	3.49e-06	6.29e-05	CcSEcCtD
Triamcinolone—Infection—Epirubicin—hematologic cancer	3.48e-06	6.27e-05	CcSEcCtD
Triamcinolone—Cough—Doxorubicin—hematologic cancer	3.46e-06	6.24e-05	CcSEcCtD
Triamcinolone—Shock—Epirubicin—hematologic cancer	3.44e-06	6.21e-05	CcSEcCtD
Triamcinolone—Convulsion—Doxorubicin—hematologic cancer	3.44e-06	6.2e-05	CcSEcCtD
Triamcinolone—Hypertension—Doxorubicin—hematologic cancer	3.43e-06	6.17e-05	CcSEcCtD
Triamcinolone—Tachycardia—Epirubicin—hematologic cancer	3.42e-06	6.16e-05	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	3.41e-06	6.14e-05	CcSEcCtD
Triamcinolone—Dizziness—Betamethasone—hematologic cancer	3.4e-06	6.12e-05	CcSEcCtD
Triamcinolone—Dizziness—Dexamethasone—hematologic cancer	3.4e-06	6.12e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Epirubicin—hematologic cancer	3.38e-06	6.1e-05	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—hematologic cancer	3.38e-06	6.1e-05	CcSEcCtD
Triamcinolone—Myalgia—Doxorubicin—hematologic cancer	3.38e-06	6.09e-05	CcSEcCtD
Triamcinolone—Paraesthesia—Methotrexate—hematologic cancer	3.36e-06	6.05e-05	CcSEcCtD
Triamcinolone—Discomfort—Doxorubicin—hematologic cancer	3.34e-06	6.02e-05	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—hematologic cancer	3.33e-06	6.01e-05	CcSEcCtD
Triamcinolone—Dry mouth—Doxorubicin—hematologic cancer	3.3e-06	5.95e-05	CcSEcCtD
Triamcinolone—Hypersensitivity—Prednisone—hematologic cancer	3.3e-06	5.94e-05	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—hematologic cancer	3.29e-06	5.93e-05	CcSEcCtD
Triamcinolone—Vomiting—Betamethasone—hematologic cancer	3.27e-06	5.89e-05	CcSEcCtD
Triamcinolone—Vomiting—Dexamethasone—hematologic cancer	3.27e-06	5.89e-05	CcSEcCtD
Triamcinolone—Rash—Betamethasone—hematologic cancer	3.24e-06	5.84e-05	CcSEcCtD
Triamcinolone—Rash—Dexamethasone—hematologic cancer	3.24e-06	5.84e-05	CcSEcCtD
Triamcinolone—Anaphylactic shock—Doxorubicin—hematologic cancer	3.24e-06	5.84e-05	CcSEcCtD
Triamcinolone—Oedema—Doxorubicin—hematologic cancer	3.24e-06	5.84e-05	CcSEcCtD
Triamcinolone—Dermatitis—Dexamethasone—hematologic cancer	3.24e-06	5.83e-05	CcSEcCtD
Triamcinolone—Dermatitis—Betamethasone—hematologic cancer	3.24e-06	5.83e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—MTR—hematologic cancer	3.23e-06	0.000209	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCG2—hematologic cancer	3.23e-06	0.000209	CbGpPWpGaD
Triamcinolone—Fatigue—Methotrexate—hematologic cancer	3.22e-06	5.81e-05	CcSEcCtD
Triamcinolone—Headache—Dexamethasone—hematologic cancer	3.22e-06	5.8e-05	CcSEcCtD
Triamcinolone—Headache—Betamethasone—hematologic cancer	3.22e-06	5.8e-05	CcSEcCtD
Triamcinolone—Infection—Doxorubicin—hematologic cancer	3.22e-06	5.8e-05	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	3.21e-06	0.000208	CbGpPWpGaD
Triamcinolone—Asthenia—Prednisone—hematologic cancer	3.21e-06	5.79e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—HMMR—hematologic cancer	3.2e-06	0.000207	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—IDH2—hematologic cancer	3.2e-06	0.000207	CbGpPWpGaD
Triamcinolone—Pain—Methotrexate—hematologic cancer	3.2e-06	5.76e-05	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—EZH2—hematologic cancer	3.19e-06	0.000207	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.19e-06	5.75e-05	CcSEcCtD
Triamcinolone—Shock—Doxorubicin—hematologic cancer	3.19e-06	5.74e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—AGO2—hematologic cancer	3.18e-06	0.000206	CbGpPWpGaD
Triamcinolone—Pruritus—Prednisone—hematologic cancer	3.17e-06	5.71e-05	CcSEcCtD
Triamcinolone—Insomnia—Epirubicin—hematologic cancer	3.17e-06	5.7e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—ENO2—hematologic cancer	3.16e-06	0.000205	CbGpPWpGaD
Triamcinolone—Tachycardia—Doxorubicin—hematologic cancer	3.16e-06	5.7e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—HDAC9—hematologic cancer	3.15e-06	0.000204	CbGpPWpGaD
Triamcinolone—Paraesthesia—Epirubicin—hematologic cancer	3.14e-06	5.66e-05	CcSEcCtD
Triamcinolone—Hyperhidrosis—Doxorubicin—hematologic cancer	3.13e-06	5.64e-05	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—PARP1—hematologic cancer	3.12e-06	0.000202	CbGpPWpGaD
Triamcinolone—Dyspnoea—Epirubicin—hematologic cancer	3.12e-06	5.62e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—H3F3B—hematologic cancer	3.12e-06	0.000202	CbGpPWpGaD
Triamcinolone—Feeling abnormal—Methotrexate—hematologic cancer	3.08e-06	5.55e-05	CcSEcCtD
Triamcinolone—Dyspepsia—Epirubicin—hematologic cancer	3.08e-06	5.55e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—GSTT1—hematologic cancer	3.07e-06	0.000199	CbGpPWpGaD
Triamcinolone—Nausea—Betamethasone—hematologic cancer	3.05e-06	5.5e-05	CcSEcCtD
Triamcinolone—Nausea—Dexamethasone—hematologic cancer	3.05e-06	5.5e-05	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	3.04e-06	0.000197	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.02e-06	0.000196	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	3.02e-06	0.000196	CbGpPWpGaD
Triamcinolone—Fatigue—Epirubicin—hematologic cancer	3.02e-06	5.44e-05	CcSEcCtD
Triamcinolone—NR3C1—Gene Expression—HDAC2—hematologic cancer	3.01e-06	0.000195	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ARNTL—hematologic cancer	3.01e-06	0.000195	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NPM1—hematologic cancer	3e-06	0.000194	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SDC1—hematologic cancer	3e-06	0.000194	CbGpPWpGaD
Triamcinolone—Pain—Epirubicin—hematologic cancer	2.99e-06	5.39e-05	CcSEcCtD
Triamcinolone—Urticaria—Methotrexate—hematologic cancer	2.97e-06	5.35e-05	CcSEcCtD
Triamcinolone—Dizziness—Prednisone—hematologic cancer	2.96e-06	5.33e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—hematologic cancer	2.96e-06	5.33e-05	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.96e-06	0.000191	CbGpPWpGaD
Triamcinolone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.95e-06	5.32e-05	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.95e-06	0.000191	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ACP5—hematologic cancer	2.93e-06	0.00019	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CA9—hematologic cancer	2.93e-06	0.00019	CbGpPWpGaD
Triamcinolone—Insomnia—Doxorubicin—hematologic cancer	2.93e-06	5.28e-05	CcSEcCtD
Triamcinolone—Paraesthesia—Doxorubicin—hematologic cancer	2.91e-06	5.24e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—NCOR2—hematologic cancer	2.89e-06	0.000187	CbGpPWpGaD
Triamcinolone—Dyspnoea—Doxorubicin—hematologic cancer	2.89e-06	5.2e-05	CcSEcCtD
Triamcinolone—Feeling abnormal—Epirubicin—hematologic cancer	2.88e-06	5.2e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—FGF19—hematologic cancer	2.87e-06	0.000186	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PHYH—hematologic cancer	2.86e-06	0.000185	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GMPS—hematologic cancer	2.86e-06	0.000185	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FTCD—hematologic cancer	2.86e-06	0.000185	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.86e-06	0.000185	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPS14—hematologic cancer	2.85e-06	0.000185	CbGpPWpGaD
Triamcinolone—Dyspepsia—Doxorubicin—hematologic cancer	2.85e-06	5.14e-05	CcSEcCtD
Triamcinolone—Vomiting—Prednisone—hematologic cancer	2.85e-06	5.13e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—DKK1—hematologic cancer	2.83e-06	0.000183	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.83e-06	0.000183	CbGpPWpGaD
Triamcinolone—Rash—Prednisone—hematologic cancer	2.82e-06	5.08e-05	CcSEcCtD
Triamcinolone—Dermatitis—Prednisone—hematologic cancer	2.82e-06	5.08e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—STAT5B—hematologic cancer	2.81e-06	0.000182	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NUP98—hematologic cancer	2.81e-06	0.000182	CbGpPWpGaD
Triamcinolone—Headache—Prednisone—hematologic cancer	2.8e-06	5.05e-05	CcSEcCtD
Triamcinolone—Fatigue—Doxorubicin—hematologic cancer	2.79e-06	5.03e-05	CcSEcCtD
Triamcinolone—Urticaria—Epirubicin—hematologic cancer	2.78e-06	5.01e-05	CcSEcCtD
Triamcinolone—Pain—Doxorubicin—hematologic cancer	2.77e-06	4.99e-05	CcSEcCtD
Triamcinolone—Body temperature increased—Epirubicin—hematologic cancer	2.77e-06	4.99e-05	CcSEcCtD
Triamcinolone—Hypersensitivity—Methotrexate—hematologic cancer	2.76e-06	4.97e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—IDH1—hematologic cancer	2.75e-06	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.75e-06	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CST3—hematologic cancer	2.74e-06	0.000178	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.73e-06	0.000177	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ADCY7—hematologic cancer	2.73e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTO1—hematologic cancer	2.72e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCC3—hematologic cancer	2.72e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—TXN—hematologic cancer	2.72e-06	0.000176	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NUP214—hematologic cancer	2.71e-06	0.000175	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.7e-06	0.000175	CbGpPWpGaD
Triamcinolone—Asthenia—Methotrexate—hematologic cancer	2.68e-06	4.84e-05	CcSEcCtD
Triamcinolone—Feeling abnormal—Doxorubicin—hematologic cancer	2.67e-06	4.81e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—SPHK1—hematologic cancer	2.67e-06	0.000173	CbGpPWpGaD
Triamcinolone—Nausea—Prednisone—hematologic cancer	2.66e-06	4.79e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—XIAP—hematologic cancer	2.65e-06	0.000172	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTR—hematologic cancer	2.65e-06	0.000172	CbGpPWpGaD
Triamcinolone—Pruritus—Methotrexate—hematologic cancer	2.65e-06	4.77e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism of proteins—CCL2—hematologic cancer	2.62e-06	0.00017	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SMPD3—hematologic cancer	2.62e-06	0.00017	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AR—hematologic cancer	2.61e-06	0.000169	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ENO2—hematologic cancer	2.6e-06	0.000168	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SMARCA4—hematologic cancer	2.58e-06	0.000167	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Epirubicin—hematologic cancer	2.58e-06	4.65e-05	CcSEcCtD
Triamcinolone—Urticaria—Doxorubicin—hematologic cancer	2.57e-06	4.64e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—UGT1A1—hematologic cancer	2.56e-06	0.000166	CbGpPWpGaD
Triamcinolone—Body temperature increased—Doxorubicin—hematologic cancer	2.56e-06	4.61e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—NQO1—hematologic cancer	2.55e-06	0.000165	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CD44—hematologic cancer	2.55e-06	0.000165	CbGpPWpGaD
Triamcinolone—Asthenia—Epirubicin—hematologic cancer	2.51e-06	4.53e-05	CcSEcCtD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	2.51e-06	0.000162	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.5e-06	0.000162	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CRABP1—hematologic cancer	2.49e-06	0.000161	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC22A1—hematologic cancer	2.49e-06	0.000161	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—HRAS—hematologic cancer	2.49e-06	0.000161	CbGpPWpGaD
Triamcinolone—Pruritus—Epirubicin—hematologic cancer	2.48e-06	4.46e-05	CcSEcCtD
Triamcinolone—Dizziness—Methotrexate—hematologic cancer	2.47e-06	4.46e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—SDC1—hematologic cancer	2.46e-06	0.00016	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALOX5—hematologic cancer	2.43e-06	0.000157	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	2.43e-06	0.000157	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYCS—hematologic cancer	2.41e-06	0.000156	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CDKN2B—hematologic cancer	2.41e-06	0.000156	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HSP90AA1—hematologic cancer	2.4e-06	0.000155	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LCK—hematologic cancer	2.39e-06	0.000155	CbGpPWpGaD
Triamcinolone—Hypersensitivity—Doxorubicin—hematologic cancer	2.39e-06	4.3e-05	CcSEcCtD
Triamcinolone—Vomiting—Methotrexate—hematologic cancer	2.38e-06	4.29e-05	CcSEcCtD
Triamcinolone—Rash—Methotrexate—hematologic cancer	2.36e-06	4.25e-05	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—hematologic cancer	2.36e-06	4.25e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—NUP98—hematologic cancer	2.35e-06	0.000152	CbGpPWpGaD
Triamcinolone—Headache—Methotrexate—hematologic cancer	2.34e-06	4.22e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—H3F3A—hematologic cancer	2.34e-06	0.000152	CbGpPWpGaD
Triamcinolone—Asthenia—Doxorubicin—hematologic cancer	2.32e-06	4.19e-05	CcSEcCtD
Triamcinolone—Dizziness—Epirubicin—hematologic cancer	2.31e-06	4.17e-05	CcSEcCtD
Triamcinolone—Pruritus—Doxorubicin—hematologic cancer	2.29e-06	4.13e-05	CcSEcCtD
Triamcinolone—CYP3A4—Metabolism—DCK—hematologic cancer	2.29e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ASNS—hematologic cancer	2.29e-06	0.000148	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—B3GAT1—hematologic cancer	2.29e-06	0.000148	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NCOR1—hematologic cancer	2.28e-06	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOA3—hematologic cancer	2.28e-06	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ADCY7—hematologic cancer	2.28e-06	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCZ—hematologic cancer	2.27e-06	0.000147	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NUP214—hematologic cancer	2.27e-06	0.000147	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.24e-06	0.000145	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CALR—hematologic cancer	2.23e-06	0.000145	CbGpPWpGaD
Triamcinolone—Vomiting—Epirubicin—hematologic cancer	2.23e-06	4.01e-05	CcSEcCtD
Triamcinolone—Nausea—Methotrexate—hematologic cancer	2.22e-06	4e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—MTR—hematologic cancer	2.22e-06	0.000144	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCG2—hematologic cancer	2.22e-06	0.000144	CbGpPWpGaD
Triamcinolone—Rash—Epirubicin—hematologic cancer	2.21e-06	3.98e-05	CcSEcCtD
Triamcinolone—Dermatitis—Epirubicin—hematologic cancer	2.2e-06	3.97e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—PARP1—hematologic cancer	2.2e-06	0.000142	CbGpPWpGaD
Triamcinolone—Headache—Epirubicin—hematologic cancer	2.19e-06	3.95e-05	CcSEcCtD
Triamcinolone—PTGS2—Metabolism—ENO2—hematologic cancer	2.18e-06	0.000141	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HDC—hematologic cancer	2.17e-06	0.000141	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FBXW7—hematologic cancer	2.16e-06	0.00014	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.16e-06	0.00014	CbGpPWpGaD
Triamcinolone—Dizziness—Doxorubicin—hematologic cancer	2.14e-06	3.86e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—GSTP1—hematologic cancer	2.13e-06	0.000138	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HDAC2—hematologic cancer	2.12e-06	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CXCR4—hematologic cancer	2.12e-06	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTT1—hematologic cancer	2.11e-06	0.000137	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD44—hematologic cancer	2.1e-06	0.000136	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.08e-06	0.000135	CbGpPWpGaD
Triamcinolone—Nausea—Epirubicin—hematologic cancer	2.08e-06	3.75e-05	CcSEcCtD
Triamcinolone—PTGS2—Disease—CBL—hematologic cancer	2.07e-06	0.000134	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SDC1—hematologic cancer	2.06e-06	0.000134	CbGpPWpGaD
Triamcinolone—Vomiting—Doxorubicin—hematologic cancer	2.06e-06	3.71e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.06e-06	0.000133	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	2.05e-06	0.000133	CbGpPWpGaD
Triamcinolone—Rash—Doxorubicin—hematologic cancer	2.04e-06	3.68e-05	CcSEcCtD
Triamcinolone—Dermatitis—Doxorubicin—hematologic cancer	2.04e-06	3.68e-05	CcSEcCtD
Triamcinolone—Headache—Doxorubicin—hematologic cancer	2.03e-06	3.66e-05	CcSEcCtD
Triamcinolone—BCHE—Metabolism—ABCB1—hematologic cancer	2.01e-06	0.00013	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CDA—hematologic cancer	1.99e-06	0.000129	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.97e-06	0.000128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HSP90AA1—hematologic cancer	1.97e-06	0.000128	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—NCOR1—hematologic cancer	1.95e-06	0.000127	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GSTM1—hematologic cancer	1.95e-06	0.000127	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.95e-06	0.000126	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	1.94e-06	0.000125	CbGpPWpGaD
Triamcinolone—Nausea—Doxorubicin—hematologic cancer	1.92e-06	3.47e-05	CcSEcCtD
Triamcinolone—CYP3A4—Metabolism—PC—hematologic cancer	1.91e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT1—hematologic cancer	1.9e-06	0.000123	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.86e-06	0.000121	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.85e-06	0.00012	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GBA—hematologic cancer	1.85e-06	0.00012	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK14—hematologic cancer	1.83e-06	0.000118	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ESR1—hematologic cancer	1.79e-06	0.000116	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GRB2—hematologic cancer	1.78e-06	0.000115	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFA—hematologic cancer	1.77e-06	0.000115	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NQO1—hematologic cancer	1.76e-06	0.000114	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CD44—hematologic cancer	1.76e-06	0.000114	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KITLG—hematologic cancer	1.75e-06	0.000113	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	1.73e-06	0.000112	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—MTHFR—hematologic cancer	1.73e-06	0.000112	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.72e-06	0.000111	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT5A—hematologic cancer	1.71e-06	0.000111	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN2B—hematologic cancer	1.69e-06	0.00011	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTAP—hematologic cancer	1.69e-06	0.000109	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYCS—hematologic cancer	1.66e-06	0.000108	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HSP90AA1—hematologic cancer	1.65e-06	0.000107	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD86—hematologic cancer	1.64e-06	0.000106	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HES1—hematologic cancer	1.62e-06	0.000105	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NCOR1—hematologic cancer	1.61e-06	0.000104	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF1—hematologic cancer	1.59e-06	0.000103	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CREBBP—hematologic cancer	1.57e-06	0.000102	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FOXO1—hematologic cancer	1.57e-06	0.000101	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFRB—hematologic cancer	1.56e-06	0.000101	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFRA—hematologic cancer	1.54e-06	9.96e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCG—hematologic cancer	1.53e-06	9.93e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAK1—hematologic cancer	1.53e-06	9.93e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.52e-06	9.86e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FHL2—hematologic cancer	1.5e-06	9.74e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.48e-06	9.62e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AGRN—hematologic cancer	1.48e-06	9.56e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTP1—hematologic cancer	1.46e-06	9.48e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—hematologic cancer	1.45e-06	9.4e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTHFR—hematologic cancer	1.42e-06	9.19e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.42e-06	9.17e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HLA-A—hematologic cancer	1.42e-06	9.17e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—hematologic cancer	1.42e-06	9.17e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HMMR—hematologic cancer	1.4e-06	9.06e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IDH2—hematologic cancer	1.4e-06	9.06e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCB1—hematologic cancer	1.39e-06	8.97e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFB—hematologic cancer	1.38e-06	8.95e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TSC2—hematologic cancer	1.35e-06	8.74e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CREBBP—hematologic cancer	1.35e-06	8.71e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—NCOR1—hematologic cancer	1.35e-06	8.71e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GSTM1—hematologic cancer	1.35e-06	8.71e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ARNTL—hematologic cancer	1.32e-06	8.52e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGFR3—hematologic cancer	1.3e-06	8.41e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CA9—hematologic cancer	1.28e-06	8.29e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACP5—hematologic cancer	1.28e-06	8.29e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—hematologic cancer	1.28e-06	8.26e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOR2—hematologic cancer	1.26e-06	8.18e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—hematologic cancer	1.26e-06	8.15e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BAD—hematologic cancer	1.23e-06	7.97e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOTCH1—hematologic cancer	1.22e-06	7.9e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3R1—hematologic cancer	1.2e-06	7.8e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—IDH1—hematologic cancer	1.2e-06	7.79e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD80—hematologic cancer	1.19e-06	7.74e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KIT—hematologic cancer	1.19e-06	7.72e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTO1—hematologic cancer	1.19e-06	7.7e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—TXN—hematologic cancer	1.19e-06	7.7e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCC3—hematologic cancer	1.19e-06	7.7e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTHFR—hematologic cancer	1.19e-06	7.7e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTPN11—hematologic cancer	1.17e-06	7.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SPHK1—hematologic cancer	1.16e-06	7.54e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CREB1—hematologic cancer	1.14e-06	7.35e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BRAF—hematologic cancer	1.12e-06	7.26e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	1.12e-06	7.24e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—hematologic cancer	1.11e-06	7.2e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6R—hematologic cancer	1.11e-06	7.17e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CREBBP—hematologic cancer	1.11e-06	7.16e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CRABP1—hematologic cancer	1.09e-06	7.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	1.09e-06	7.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALOX5—hematologic cancer	1.06e-06	6.87e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAP2K1—hematologic cancer	1.06e-06	6.83e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—hematologic cancer	1.05e-06	6.79e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.05e-06	6.78e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NUP98—hematologic cancer	1.03e-06	6.65e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF2—hematologic cancer	1e-06	6.5e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—hematologic cancer	9.99e-07	6.47e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOA3—hematologic cancer	9.97e-07	6.45e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ADCY7—hematologic cancer	9.97e-07	6.45e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3R1—hematologic cancer	9.9e-07	6.41e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NUP214—hematologic cancer	9.9e-07	6.41e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTR—hematologic cancer	9.7e-07	6.28e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCG2—hematologic cancer	9.7e-07	6.28e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—JAK2—hematologic cancer	9.62e-07	6.23e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—hematologic cancer	9.61e-07	6.22e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK3—hematologic cancer	9.59e-07	6.21e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ENO2—hematologic cancer	9.51e-07	6.16e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MDM2—hematologic cancer	9.39e-07	6.08e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—hematologic cancer	9.33e-07	6.04e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CREBBP—hematologic cancer	9.26e-07	6e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTT1—hematologic cancer	9.22e-07	5.97e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—EP300—hematologic cancer	9.16e-07	5.93e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MTOR—hematologic cancer	9.14e-07	5.92e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—hematologic cancer	9.14e-07	5.92e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD4—hematologic cancer	9.12e-07	5.91e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SDC1—hematologic cancer	9.01e-07	5.84e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—hematologic cancer	8.78e-07	5.69e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—hematologic cancer	8.67e-07	5.61e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1B—hematologic cancer	8.58e-07	5.55e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3R1—hematologic cancer	8.29e-07	5.37e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1A—hematologic cancer	7.91e-07	5.13e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—hematologic cancer	7.9e-07	5.11e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CD44—hematologic cancer	7.66e-07	4.96e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NQO1—hematologic cancer	7.66e-07	4.96e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—hematologic cancer	7.65e-07	4.96e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EP300—hematologic cancer	7.53e-07	4.88e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SRC—hematologic cancer	7.32e-07	4.74e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYCS—hematologic cancer	7.25e-07	4.7e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	7.21e-07	4.67e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—hematologic cancer	7.06e-07	4.57e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NRAS—hematologic cancer	7.05e-07	4.56e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—hematologic cancer	6.78e-07	4.39e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK3—hematologic cancer	6.75e-07	4.37e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—hematologic cancer	6.61e-07	4.28e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—hematologic cancer	6.56e-07	4.25e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TGFB1—hematologic cancer	6.55e-07	4.24e-05	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—hematologic cancer	6.47e-07	4.19e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTP1—hematologic cancer	6.39e-07	4.14e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—EP300—hematologic cancer	6.31e-07	4.08e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—hematologic cancer	6.06e-07	3.93e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCB1—hematologic cancer	6.05e-07	3.92e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—NCOR1—hematologic cancer	5.87e-07	3.8e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GSTM1—hematologic cancer	5.87e-07	3.8e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—hematologic cancer	5.57e-07	3.61e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—hematologic cancer	5.54e-07	3.59e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTHFR—hematologic cancer	5.19e-07	3.36e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HRAS—hematologic cancer	5.15e-07	3.34e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—hematologic cancer	4.93e-07	3.19e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—hematologic cancer	4.67e-07	3.02e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—hematologic cancer	4.55e-07	2.95e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	4.36e-07	2.82e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CREBBP—hematologic cancer	4.04e-07	2.62e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	3.83e-07	2.48e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—hematologic cancer	3.81e-07	2.47e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—hematologic cancer	3.79e-07	2.45e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	3.62e-07	2.34e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	3.34e-07	2.16e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—hematologic cancer	2.89e-07	1.87e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—EP300—hematologic cancer	2.75e-07	1.78e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	2.04e-07	1.32e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—hematologic cancer	1.66e-07	1.08e-05	CbGpPWpGaD
